Induced sputum and peripheral blood cell profile in chronic obstructive pulmonary disease;Perfil celular do escarro induzido e sangue periférico na doença pulmonar obstrutiva crônica

Jornal Brasileiro de Pneumologia

Volumn 33, Issue 5, 2007, Pages 510-518

  Rufino, Rogerio ^a   Da Costa, Cláudia Henrique ^a   De Souza, Heitor Siffert Pereira ^b   Madi, Kalil ^b   E Silva, José Roberto Lapa ^b  

^a UNIVERSIDADE DO ESTADO DO RIO DE JANEIRO   (Brazil)

^b FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

Author keywords

Eosinophils; Macrophages; Neutrophils; Pulmonary disease, chronic obstructive; Sputum; T lymphocytes

Indexed keywords

BIOLOGICAL MARKER;

ADULT; ARTICLE; BLOOD; CASE CONTROL STUDY; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CYTOLOGY; EOSINOPHIL; FEMALE; FORCED EXPIRATORY VOLUME; HUMAN; LYMPHOCYTE COUNT; MACROPHAGE; MALE; MIDDLE AGED; NEUTROPHIL; NONPARAMETRIC TEST; PATHOLOGY; SMOKING; SPUTUM; VITAL CAPACITY;

ADULT; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; EOSINOPHILS; FEMALE; FORCED EXPIRATORY VOLUME; HUMANS; LYMPHOCYTE COUNT; MACROPHAGES; MALE; MIDDLE AGED; NEUTROPHILS; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; SMOKING; SPUTUM; STATISTICS, NONPARAMETRIC; VITAL CAPACITY;

EID: 41549103313     PISSN: 18063713     EISSN: 18063713     Source Type: Journal    
DOI: 10.1590/S1806-37132007000500005     Document Type: Article

References (30)

1. GOLD - Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease [Homepage on the Internet]. Executive Summary, Global Strategy for the Diagnosis, Management, and Prevention of COPD Updated 2005 [cited 2006 Sep 9]. Available from: http://www.goldcopd.org/ Guidelineitem.asp?l1=2&l2=1&intId=1662
2. Walker RI, Willemze R. Neutrophil kinetics and the regulation of granulopoiesis. Rev Infect Dis. 1980;2(2):282-92.
3. Cosio MG, Guerassimov A. Chronic obstructive pulmonary disease. Inflammation of small airways and lung parenchyma. Am J Respir Crit Care Med. 1999;160(5 Pt 2):S21-5.
4. Cosio M, Ghezzo H, Hogg JC, Corbin R, Loveland M, Dosman J, et al. The relations between structural changes in small airways and pulmonary-function tests. N Engl J Med. 1978;298(23):1277-81.
5. Janoff A. Elastases and emphysema. Current assessment of the protease-antiprotease hypothesis. Am Rev Respir Dis. 1985;132(2):417-33.
6. Barnes PJ, Shapiro SD, Pauwels RA. Chronic obstructive pulmonary disease: molecular and cellular mechanisms. Eur Respir J. 2003;22(4):672-88.
7. Hogg JC. Pathophysiology of airflow limitation in chronic obstructive pulmonary disease. Lancet. 2004;364(9435):709-21.
8. Shapiro SD. Evolving concepts in the pathogenesis of chronic obstructive pulmonary disease. Clin Chest Med. 2000;21(4):621-32.
9. Di Stefano A, Capelli A, Lusuardi M, Balbo P, Vecchio C, Maestrelli P, et al. Severity of airflow limitation is associated with severity of airway inflammation in smokers. Am J Respir Crit Care Med. 1998;158(4):1277-85.
10. Turato G, Zuin R, Miniati M, Baraldo S, Rea F, Beghe B, et al. Airway inflammation in severe chronic obstructive pulmonary disease: relationship with lung function and radiologic emphysema. Am J Respir Crit Care Med. 2002;166(1):105-10.
11. Amadori A, Zamarchi R, De Silvestro G, Forza G, Cavatton G, Danieli GA, et al. Genetic control of the CD4/CD8 T-cell ratio in humans. Nat Med. 1995;1(12):1279-83.
12. Pin I, Gibson PG, Kolendowicz R, Girgis-Gabardo A, Denburg JA, Hargreave FE, et al. Use of induced sputum cell counts to investigate airway inflammation in asthma. Thorax. 1992;47(1):25-9.
13. O'Donnell R, Breen D, Wilson S, Djukanovic R. Inflammatory cells in the airways in COPD. Thorax. 2006;61(5):448-54.
14. Lung function testing: selection of reference values and interpretative strategies. American Thoracic Society. Am Rev Respir Dis. 1991;144(5):1202-18.
15. Hogg JC, Chu F, Utokaparch S, Woods R, Elliott WM, Buzatu L, et al. The nature of small-airway obstruction in chronic obstructive pulmonary disease. N Engl J Med. 2004;350(26):2645-53.
16. O'Shaughnessy TC, Ansari TW, Barnes NC, Jeffery PK. Inflammation in bronchial biopsies of subjects with chronic bronchitis: inverse relationship of CD8+ T lymphocytes with FEV1. Am J Respir Crit Care Med. 1997;155(3):852-7.
17. Saetta M, Di Stefano A, Turato G, Facchini FM, Corbino L, Mapp CE, et al. CD8+ T-lymphocytes in peripheral airways of smokers with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 1998;157(3 Pt 1):822-6.
18. Bosken CH, Hards J, Gatter K, Hogg JC. Characterization of the inflammatory reaction in the peripheral airways of cigarette smokers using immunocytochemistry. Am Rev Respir Dis. 1992;145(4 Pt 1):911-7.
19. Kips JC, Peleman RA, Pauwels RA. Methods of examining induced sputum: do differences matter? Eur Respir J. 1998;11(3):529-33.
20. Parameswaran K, Pizzichini MM, Li D, Pizzichini E, Jeffery PK, Hargreave FE. Serial sputum cell counts in the management of chronic airflow limitation. Eur Respir J. 1998;11(6):1405-8.
21. Barnes PJ. Mediators of chronic obstructive pulmonary disease. Pharmacol Rev. 2004;56(4):515-48.
22. Cosio MG, Majo J, Cosio MG. Inflammation of the airways and lung parenchyma in COPD: role of T cells. Chest. 2002;121(5 Suppl):160S-165S.
23. Hogg JC, Senior RM. Chronic obstructive pulmonary disease - part 2: pathology and biochemistry of emphysema. Thorax. 2002;57(9):830-4.
24. Shaw RJ, Djukanovic R, Tashkin DP, Millar AB, du Bois RM, Orr PA. The role of small airways in lung disease. Respir Med. 2002 Feb;96(2):67-80.
25. Liu CC, Young LH, Young JD. Lymphocyte-mediated cytolysis and disease. N Engl J Med. 1996;335(22):1651-9.
26. O'Connor GT, Sparrow D, Weiss ST. The role of allergy and nonspecific airway hyperresponsiveness in the pathogenesis of chronic obstructive pulmonary disease. Am Rev Respir Dis. 1989;140(1):225-52.
27. Sluiter HJ, Koëter GH, de Monchy JG, Postma DS, de Vries K, Orie NG. The Dutch hypothesis (chronic non-specific lung disease) revisited. Eur Respir J. 1991;4(4):479-89.
28. Saetta M. Airway inflammation in chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 1999;160(5 Pt 2):S17-20.
29. Pizzichini E, Pizzichini MM, Gibson P, Parameswaran K, Gleich GJ, Berman L, et al. Sputum eosinophilia predicts benefit from prednisone in smokers with chronic obstructive bronchitis. Am J Respir Crit Care Med. 1998;158(5 Pt 1):1511-7.
30. Saetta M, Di Stefano A, Maestrelli P, Turato G, Ruggieri MP, Roggeri A, et al. Airway eosinophilia in chronic bronchitis during exacerbations. Am J Respir Crit Care Med. 1994;150(6 Pt 1):1646-52.